X-FAB First Quarter 2025 Results

Business Wire
24 Apr

Intermediate declaration by the Board of Directors

TESSENDERLO-HAM, Belgium, April 24, 2025--(BUSINESS WIRE)--Regulatory News:

X-FAB (BOURSE:XFAB):

Highlights Q1 2025:

  • Revenue was USD 204.1 million, down 6% year-on-year (YoY) and up 8% quarter-on-quarter (QoQ)
  • Excluding the impact from revenue recognized over time (IFRS 15), revenue was USD 202.3 million, well within the guided range of USD 195-205 million
  • Bookings at USD 174.7 million reflecting a strong sequential increase of 26% QoQ
  • EBITDA at USD 49.1 million, down 4% YoY and up 23% QoQ
  • EBITDA margin of 24.0%; excluding IFRS 15 impact, EBITDA margin was 23.8%, compared to the guidance of 22-25%
  • EBIT was USD 21.1 million, down 22% YoY and up 100% QoQ

Outlook:

  • Q2 2025 revenue is expected to come in within a range of USD 200-210 million with an EBITDA margin in the range of 22.5-25.5%.
  • The guidance is based on an average exchange rate of 1,08 USD/Euro and does not take into account the impact of IFRS 15.
  • X-FAB reiterates its FY 2025 guidance with annual revenue expected in the range of USD 820-870 million and an EBITDA margin in the range of 24-27%.

Revenue breakdown per quarter:

in millions of USD

Q2 2023

Q3 2023

Q4 2023

Q1 2024

Q2 2024

Q3 2024

Q4 2024

Q1 2025

Q1 y-o-y growth

Automotive

131.1

135.3

151.8

135.6

142.4

146.0

128.6

135.4

0%

Industrial

51.3

53.7

54.3

52.6

34.4

31.5

36.1

39.3

-25%

Medical

16.2

17.0

16.4

14.5

13.2

12.1

16.5

13.8

-4%

Subtotal core business

198.7

206.1

222.5

202.6

190.1

189.6

181.2

188.6

-7%

90.8%

92.2%

92.8%

92.6%

93.7%

92.9%

92.1%

93.2%

CCC1

20.0

17.2

17.2

16.0

12.6

14.2

15.1

13.6

-15%

Others

0.2

0.2

0.1

0.1

0.1

0.1

0.5

0.2

Revenue*

218.9

223.5

239.8

218.7

202.8

204.0

196.8

202.3

-7%

Impact from revenue recognized over time

8.3

10.4

-2.0

-2.6

2.3

2.4

-8.0

1.8

Total revenue

227.1

233.8

237.7

216.2

205.1

206.4

188.8

204.1

-6%

1Consumer, Communications & Computer

in millions of USD

Q2 2023

Q3 2023

Q4 2023

Q1 2024

Q2 2024

Q3 2024

Q4 2024

Q1 2025

Q1 y-o-y growth

CMOS

180.7

180.5

188.4

168.3

166.2

175.0

170.8

173.4

3%

Microsystems

20.8

24.4

27.9

24.1

25.1

21.6

20.2

22.9

-5%

Silicon carbide

17.3

18.6

23.5

26.3

11.6

7.4

5.8

6.0

-77%

Revenue*

218.9

223.5

239.8

218.7

202.8

204.0

196.8

202.3

-7%

Impact from revenue recognized over time

8.3

10.4

-2.0

-2.6

2.3

2.4

-8.0

1.8

Total revenue

227.1

233.8

237.7

216.2

205.1

206.4

188.8

204.1

-6%

Business development

In the first quarter of 2025, X-FAB recorded revenues of USD 204.1 million, down 6% year-on-year and up 8% quarter-on-quarter. Excluding the impact from revenue recognized over time in the amount of USD 1.8 million, quarterly revenue was USD 202.3 million, which is well within the guidance of USD 195‑205 million.

First quarter revenue in X-FAB’s core markets – automotive, industrial, and medical – was at USD 188.6 million*, down 7% year-on-year and up 4% quarter-on-quarter, representing a share of 93%* of total revenue.

The quarterly bookings totaled USD 174.7 million, reflecting a 36% decrease compared to the exceptionally strong corresponding quarter of the previous year, but a 26% increase quarter-on-quarter. This growth is primarily related to strong bookings in the automotive and industrial end market. In general, customers are still placing orders later than usual in reaction to the currently shortened lead times. The backlog for the first quarter amounted to USD 386.7 million, compared to USD 414.0 million at the end of the previous quarter.

In the first quarter, X-FAB recorded automotive revenue of USD 135.4 million*, flat year-on-year and up 5% sequentially. Main drivers for X-FAB’s automotive business in the first quarter were EV-related applications. Industrial revenue in the first quarter came in at USD 39.3 million*, down 25% year-on-year and up 9% quarter-on-quarter. The industrial business in particular is benefiting from increased demand following the last-time-buy announcement for some of X-FAB’s 150mm CMOS technologies. Revenue in the medical end market amounted to USD 13.8 million*, down 4% year-on-year, while the quarter-on-quarter decline of 16% is attributable to high shipments of a medical application in the prior quarter.

X-FAB recorded a sequential revenue increase across all technologies. CMOS revenue went up 2%* quarter-on-quarter, silicon carbide 5%* and X-FAB’s microsystems business 14%*. X-FAB’s silicon carbide revenue in the first quarter came in at USD 6.0 million*. SiC order intake increased 17% sequentially and for the second consecutive quarter, signaling the market’s gradual recovery. The main growth driver was data center applications.

Quarterly prototyping revenue was USD 16.1 million*, down 31% year-on-year and 32% quarter-on-quarter. As the transition of major customer-specific projects to volume production was successfully completed in 2024, the associated safe launch and start-up costs as part of prototyping revenue disappeared, which had an effect on the prototyping revenue in the first quarter. In general, X FAB's prototyping revenue tends to be more variable as the number of customer-specific projects increases. In these projects, development and prototyping services are billed in tranches based on milestones achieved rather than on a linear basis.

Prototyping and production revenue* per quarter and end market:

in millions

of USD

Revenue

Q1 2024

Q2 2024

Q3 2024

Q4 2024

Q1 2025

Automotive

Prototyping

6.7

7.6

9.3

8.9

4.7

Production

128.9

134.8

136.7

119.7

130.8

Industrial

Prototyping

10.7

8.9

8.2

9.6

8.8

Production

41.9

25.5

23.3

26.5

30.5

Medical

Prototyping

2.7

2.0

3.0

2.3

1.5

Production

11.8

11.2

9.1

14.2

12.3

CCC

Prototyping

3.1

2.5

3.0

2.6

1.1

Production

12.9

10.2

11.3

12.6

12.5

The megatrends "electrification of everything" and "sensing everywhere" will drive sustainable demand for the comprehensive set of specialty technologies that X-FAB offers, enabling viable solutions that contribute to the mitigation of climate change and more efficient digital healthcare in aging societies. With the phase-out of inventory corrections and the expected gradual recovery of demand in the course of 2025, X-FAB reiterates its full-year guidance with a revenue range of USD 820-870 million and an EBITDA margin in the range of 24-27%.

Geopolitical tensions and related customs regulations do not currently impact X-FAB's business directly, as X‑FAB sells its goods ex-works. The indirect effects of these tensions can be either positive or negative and cannot be estimated. This guidance accounts for all identified effects as of the date of this press release.

Operations update

X-FAB progressed well in expanding its 180nm CMOS capacity, which is crucial for supporting its future CMOS and microsystems business. During the first quarter, all outstanding tools for the newly constructed clean room in Malaysia were delivered, installed, and are now being qualified.

This marks the approaching completion of X-FAB's major capacity expansion program. The associated capital expenditures are anticipated to be finalized within the first half of 2025. In the first quarter, capital expenditures totaled USD 101.7 million, representing a decrease of 23% compared to the previous quarter.

Financial update

First quarter EBITDA was USD 49.1 million with an EBITDA margin of 24.0%. Excluding the impact from revenues recognized over time, the EBITDA margin for the first quarter would have been 23.8%, within the guided range of 22-25%.

For the net financial result in the first quarter X-FAB recorded a loss of USD 7.2 million, which includes unrealized foreign exchange effects totaling USD -3.4 million.

Profitability remains unaffected by exchange rate fluctuations as X-FAB’s business is naturally hedged. At a constant USD/Euro exchange rate of 1.09 as experienced in the previous year’s quarter, the EBITDA margin would have been 0.1 percentage points higher.

Cash and cash equivalents at the end of the first quarter amounted to USD 157.2 million, down 27% against the previous quarter in accordance with the planned allocation of funds to capital expenditures.

Management comments

Rudi De Winter, CEO of X-FAB Group, said: "I am pleased to present the quarterly results reflecting X-FAB’s resilient business with an 8% sequential increase in revenue and a robust EBITDA margin of 24%. Although geopolitical tensions pose challenges for the semiconductor industry, they also offer new opportunities for X‑FAB due to our global presence across all major continents. I am confident in our capacity to navigate these challenges, as our specialty technologies address societal megatrends and will continue to be in demand."

X-FAB Quarterly Conference Call

X-FAB’s first quarter results will be discussed in a live conference call/audiocast on Thursday, April 24, 2025, at 6.30 p.m. CEST. The conference call will be in English.

Please register here for the audiocast (listen only).

Please register here for the conference call (listen and ask questions).

The second quarter 2025 results will be communicated on July 31, 2025.

About X-FAB

X-FAB is a global foundry group providing a comprehensive set of specialty technologies and design IP to enable its customers to develop world-leading semiconductor products that are manufactured at X-FAB's six wafer fabs located in Malaysia, Germany, France, and the United States. With its expertise in analog/mixed-signal technologies, microsystems/MEMS and silicon carbide (SiC), X-FAB is the development and manufacturing partner for its customers, primarily serving the automotive, industrial and medical end markets. X-FAB has approximately 4,500 employees and has been listed on Euronext Paris since April 2017 (XFAB). For more information, please visit www.xfab.com.

Forward-looking information

This press release may include forward-looking statements. Forward-looking statements are statements regarding or based upon our management’s current intentions, beliefs or expectations relating to, among other things, X-FAB’s future results of operations, financial condition, liquidity, prospects, growth, strategies, or developments in the industry in which we operate. By their nature, forward-looking statements are subject to risks, uncertainties and assumptions that could cause actual results or future events to differ materially from those expressed or implied thereby. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein.

Forward-looking statements contained in this press release regarding trends or current activities should not be taken as a report that such trends or activities will continue in the future. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless legally required. You should not place undue reliance on any such forward-looking statements, which speak only as of the date of this press release.

The information contained in this press release is subject to change without notice. No re-report or warranty, express or implied, is made as to the fairness, accuracy, reasonableness, or completeness of the information contained herein and no reliance should be placed on it.

Condensed consolidated statement of profit and loss

in thousands of USD

Quarter

ended
31 Mar 2025

unaudited

Quarter

ended
31 Mar 2024

unaudited

Quarter

ended
31 Dec 2024

unaudited

Year

ended
31 Dec 2024

audited

Revenue*

202,332

218,712

196,761

822,301

Impact from revenue recognized over time

1,781

-2,559

-7,998

-5,919

Total revenue

204,113

216,152

188,762

816,383

Revenues in USD in %

58

62

61

59

Revenues in EUR in %

42

38

39

41

Cost of sales

-159,476

-165,786

-152,250

-633,434

Gross profit

44,636

50,367

36,513

182,949

Gross profit margin in %

21.9

23.3

19.3

22.4

Research and development expenses

-10,992

-11,106

-14,205

-49,785

Selling expenses

-2,248

-2,537

-2,213

-9,070

General and administrative expenses

-11,397

-12,811

-11,511

-47,351

Rental income and expenses from investment properties

776

1,434

409

2,770

Other income and other expenses

337

1,847

1,575

6,030

Operating profit

21,112

27,193

10,567

85,543

Finance income

6,494

5,778

11,262

36,006

Finance costs

-13,684

-7,653

-12,243

-38,260

Net financial result

-7,190

-1,875

-981

-2,254

Profit before tax

13,922

25,318

9,585

83,289

Income tax

-1,720

-2,260

-16,891

-21,763

Profit for the period

12,202

23,059

-7,306

61,526

Operating profit (EBIT)

21,112

27,193

10,567

85,542

Depreciation

27,949

23,765

29,248

103,386

EBITDA

49,061

50,958

39,815

188,928

EBITDA margin in %

24.0

23.6

21.1

23.1

Earnings per share

0.09

0.18

-0.06

0.47

Weighted average number of shares

130,631,921

130,631,921

130,631,921

130,631,921

EUR/USD average exchange rate

1.05149

1.08605

1.06821

1.08232

Amounts in the financial tables provided in this press release are rounded to the nearest thousand except when otherwise indicated, rounding differences may occur.

*excluding impact from revenue recognized over time in accordance with IFRS 15

Condensed consolidated statement of financial position

in thousands of USD

Quarter ended

31 Mar 2025

unaudited

Quarter ended

31 Mar 2024

unaudited

Year ended

31 Dec 2024

audited

ASSETS

Non-current assets

Property, plant, and equipment

1,196,149

800,843

1,144,620

Investment properties

7,339

7,108

7,412

Intangible assets

6,059

5,985

6,319

Other non-current assets

38

54

42

Deferred tax assets

66,855

83,692

66,725

Total non-current assets

1,276,440

897,682

1,225,118

Current assets

Inventories

281,311

276,983

281,765

Contract assets

19,873

21,451

18,092

Trade and other receivables

95,310

119,271

96,648

Other assets

62,696

48,786

69,253

Cash and cash equivalents

157,240

351,468

215,837

Total current assets

616,430

817,959

681,595

TOTAL ASSETS

1,892,870

1,715,640

1,906,713

EQUITY AND LIABILITIES

Equity

Share capital

432,745

432,745

432,745

Share premium

348,709

348,709

348,709

Retained earnings

253,858

203,218

241,648

Cumulative translation adjustment

369

-1,052

462

Treasury shares

-770

-770

-770

Total equity

1,034,911

982,850

1,022,794

Non-current liabilities

Non-current loans and borrowings

375,835

58,778

369,616

Other non-current liabilities and provisions

3,905

4,696

4,257

Total non-current liabilities

379,740

63,474

373,873

Current liabilities

Trade payables

41,068

102,660

67,658

Current loans and borrowings

50,492

185,400

44,517

Other current liabilities and provisions

386,660

381,258

397,872

Total current liabilities

478,219

669,317

510,046

TOTAL EQUITY AND LIABILITIES

1,892,870

1,715,640

1,906,713

Condensed consolidated statement of cash flows

in thousands of USD

Quarter

ended
31 Mar 2025

unaudited

Quarter

ended
31 Mar 2024

unaudited

Quarter

ended
31 Dec 2024

unaudited

Year

ended
31 Dec 2024

audited

Income before taxes

13,922

25,318

9,585

83,289

Reconciliation of income before taxes to cash flow arising from operating activities:

30,949

23,732

31,455

106,148

Depreciation and amortization, before effect of grants and subsidies

27,949

23,765

29,248

103,386

Amortization of investment grants and subsidies

-1,231

-673

-1,514

-3,735

Interest income and expenses (net)

3,756

-306

2,564

5,525

Loss/(gain) on the sale of plant, property, and equipment (net)

-53

-1,751

53

-4,030

Loss/(gain) on the change in fair value of derivatives and financial assets (net)

0

0

0

1,144

Other non-cash transactions (net)

529

2,698

1,104

3,858

Changes in working capital:

-6,783

-799

-27,694

8,726

Decrease/(increase) of trade receivables

1,296

8,252

-5,347

30,808

Decrease/(increase) of other receivables and other assets

6,562

6,587

-14,504

5,687

Decrease/(increase) of inventories

454

-4,951

2,380

-9,733

Decrease/(increase) of contract assets

-1,781

2,559

7,998

5,919

(Decrease)/increase of trade payables

-4,151

-206

525

-17,373

(Decrease)/increase of other liabilities

-9,163

-13,040

-18,746

-6,582

Income taxes (paid)/received

-896

-1,441

-359

-2,113

Net cash from operating activities

37,192

46,810

12,987

196,050

Cash flow from investing activities:

Payments for property, plant, equipment and intangible assets

-101,731

-104,980

-132,903

-509,551

Acquisition of subsidiary, net of cash acquired

0

23,229

0

-1,633

Proceeds from sale of property, plant, and equipment

53

1,791

-99

4,024

Interest received

1,164

3,433

1,972

11,032

Net cash used in investing activities

-100,514

-76,527

-131,030

-496,128

Condensed consolidated statement of cash flows – con’t

in thousands of USD

Quarter

ended
31 Mar 2025

unaudited

Quarter

ended
31 Mar 2024

unaudited

Quarter

ended
31 Dec 2024

unaudited

Year

ended
31 Dec 2024

audited

Cash flow from (used in) financing activities:

Proceeds from loans and borrowings

28,902

50,300

38,134

209,669

Repayment of loans and borrowings

-21,081

-94,113

-3,898

-124,237

Receipts of sale and leaseback arrangements

3,095

31,616

1,350

60,584

Payments of lease installments

-4,146

-1,169

-3,193

-12,502

Interest paid

-4,817

-4,058

-3,749

-17,214

Cash flow from (used in) financing activities

1,953

-17,423

28,644

116,300

Effect of changes in foreign currency exchange rates on cash balances

2,771

-7,093

-10,681

-6,086

Increase/(decrease) of cash and cash equivalents

-61,368

-47,140

-89,399

-183,778

Cash and cash equivalents at the beginning of the period

215,837

405,701

315,917

405,701

Cash and cash equivalents at the end of

the period

157,240

351,468

215,837

215,837

*excluding impact from revenue recognized over time according to IFRS 15

View source version on businesswire.com: https://www.businesswire.com/news/home/20250423378830/en/

Contacts

X-FAB Press Contact
Uta Steinbrecher
Investor Relations
X-FAB Silicon Foundries
+49-361-427-6489
uta.steinbrecher@xfab.com




Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10